[go: up one dir, main page]

CN110575181A - Near-infrared spectroscopy non-invasive blood glucose detection network model training method - Google Patents

Near-infrared spectroscopy non-invasive blood glucose detection network model training method Download PDF

Info

Publication number
CN110575181A
CN110575181A CN201910853592.4A CN201910853592A CN110575181A CN 110575181 A CN110575181 A CN 110575181A CN 201910853592 A CN201910853592 A CN 201910853592A CN 110575181 A CN110575181 A CN 110575181A
Authority
CN
China
Prior art keywords
blood glucose
network
training
sample data
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910853592.4A
Other languages
Chinese (zh)
Inventor
季忠
程锦绣
李孟泽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing University
Original Assignee
Chongqing University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing University filed Critical Chongqing University
Priority to CN201910853592.4A priority Critical patent/CN110575181A/en
Publication of CN110575181A publication Critical patent/CN110575181A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A61B5/02055Simultaneously evaluating both cardiovascular condition and temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/359Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00Computing arrangements based on biological models
    • G06N3/02Neural networks
    • G06N3/04Architecture, e.g. interconnection topology
    • G06N3/045Combinations of networks
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00Computing arrangements based on biological models
    • G06N3/02Neural networks
    • G06N3/08Learning methods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Computational Linguistics (AREA)
  • General Engineering & Computer Science (AREA)
  • Software Systems (AREA)
  • Mathematical Physics (AREA)
  • Computing Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Physiology (AREA)
  • Evolutionary Computation (AREA)
  • Artificial Intelligence (AREA)
  • Data Mining & Analysis (AREA)
  • Optics & Photonics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

本发明涉及一种近红外光谱无创血糖检测网络模型训练方法,属于生理信号采集技术和数字信号分析技术领域。先利用环境温度、环境湿度、收缩压、舒张压、脉率、体温和单波长近红外吸光度及对应的有创血糖浓度数据训练得到BP人工神经网络,在其基础上进行敏感度分析,筛选出收缩压、脉率、体温和单波长近红外吸光度共4个变量作为NARX模型的输入变量,训练得到最终的NARX检测模型;利用本发明所得的检测模型进行近红外光无创血糖检测时,只需采集上述4个变量,和两次有创血糖浓度值,便能够得到后续的近红外光无创血糖浓度检测结果,利用该检测网络模型进行近红外光无创血糖检测具有较高的检测精度能够很好的满足临床需求。

The invention relates to a near-infrared spectrum non-invasive blood sugar detection network model training method, which belongs to the technical fields of physiological signal collection technology and digital signal analysis. Firstly, the BP artificial neural network is obtained by training the data of ambient temperature, ambient humidity, systolic blood pressure, diastolic blood pressure, pulse rate, body temperature, single-wavelength near-infrared absorbance and corresponding invasive blood sugar concentration, and then conducts sensitivity analysis on the basis of which to screen out Four variables including systolic blood pressure, pulse rate, body temperature and single-wavelength near-infrared absorbance are used as input variables of the NARX model, and the final NARX detection model is obtained through training; By collecting the above four variables and two invasive blood sugar concentration values, the subsequent near-infrared light non-invasive blood sugar concentration detection results can be obtained. Using this detection network model for near-infrared light non-invasive blood sugar detection has high detection accuracy and can be very good. meet clinical needs.

Description

近红外光谱无创血糖检测网络模型训练方法Near-infrared spectroscopy non-invasive blood glucose detection network model training method

技术领域technical field

本发明属于生理信号采集技术和数字信号分析技术领域,涉及近红外光谱无创血糖检测网络模型训练方法。The invention belongs to the technical fields of physiological signal collection technology and digital signal analysis, and relates to a near-infrared spectrum non-invasive blood sugar detection network model training method.

背景技术Background technique

目前已有的血糖检测方法主要分为有创、微创和无创三大类。其中有创和微创类检测方法包括自动生化仪测量法和快速血糖仪测量方法等,其检测精度高,但频繁的检测会给患者带来不必要的麻烦与精神压力,长期的创伤会给患者留下疼痛甚至心理阴影,若处理不当还会留下被感染的可能。因而,一种无创伤血糖浓度监测方法对于糖尿病患者而言具有非常重要的现实意义,减轻患者苦痛,血糖依赖相关的药物可以得到更有效地控制,提高患者的生活质量。At present, the existing blood glucose detection methods are mainly divided into three categories: invasive, minimally invasive and non-invasive. Among them, invasive and minimally invasive detection methods include automatic biochemical instrument measurement method and rapid blood glucose meter measurement method, etc., which have high detection accuracy, but frequent detection will bring unnecessary trouble and mental stress to patients, and long-term trauma will cause The patient is left with pain and even a psychological shadow. If it is not handled properly, it will also leave the possibility of infection. Therefore, a non-invasive blood glucose concentration monitoring method has very important practical significance for diabetic patients, which can reduce the suffering of patients, and the drugs related to blood glucose dependence can be controlled more effectively and improve the quality of life of patients.

主要无创血糖浓度监测方法主要分为两大类:液体收集方法与光学方法。前者包括间质液透皮收集法和离子电渗透法,后者包括中红外光谱法、近红外光谱法、光声光谱法、拉曼光谱法、旋光法、光散射系数法等。在众多的无创血糖测量方法中,近红外光谱测量法以其穿透皮肤的深度较深、仪器设备成本相对较低,且光能量相对比较小,对人体无伤害等优点,成为了人体血糖浓度无创测量研究领域的最有前景的方法之一。该技术已被用于手指,下唇,前臂,耳垂,舌,脸颊等部位进行血糖浓度的无创检测。The main non-invasive blood glucose concentration monitoring methods are mainly divided into two categories: liquid collection methods and optical methods. The former includes transdermal collection of interstitial fluid and iontophoresis, while the latter includes mid-infrared spectroscopy, near-infrared spectroscopy, photoacoustic spectroscopy, Raman spectroscopy, optical rotation, and light scattering coefficient methods. Among the many non-invasive blood glucose measurement methods, near-infrared spectroscopy has become the most widely used method for human blood glucose concentration due to its deep penetration into the skin, relatively low equipment cost, relatively small light energy, and no harm to the human body. One of the most promising approaches in the field of noninvasive measurement research. This technology has been used for non-invasive detection of blood glucose concentration in fingers, lower lip, forearm, earlobe, tongue, cheek and other parts.

近红外光谱进行血糖浓度无创检测的理论基础是比尔-朗伯定律:其中Aλ为特定波长λ下血糖的吸光度,I0(λ)为透射光强度,I(λ)为经过人体组织后的透射光强度,ε(λ)为吸光系数,l为光程长,c为血糖的浓度。比尔-朗伯定律适用于均匀的非散射体系,要求吸光质点之间不存在相互作用。The theoretical basis for the non-invasive detection of blood glucose concentration by near-infrared spectroscopy is the Beer-Lambert law: Where A λ is the absorbance of blood sugar at a specific wavelength λ, I 0 (λ) is the transmitted light intensity, I(λ) is the transmitted light intensity after passing through human tissue, ε(λ) is the absorption coefficient, l is the optical path length, c is the concentration of blood sugar. Beer-Lambert's law applies to uniform non-scattering systems, requiring no interaction between light-absorbing particles.

稳定可靠的定量模型是近红外无创血糖检测技术的一个关键技术。很多研究中采用了诸如多元线性回归(MLR)、主成分回归(PCR)和偏最小二乘回归(PLS)等线性模型。但由于血液成分的复杂性以及各组分之间的相互作用,基于朗伯-比尔定律的线性方法可能无法很好的拟合近红外吸光度和人体血糖浓度的关系。另一方面,体外检测到关于血糖的光学信号非常微弱且极其容易受到人体生理参数和体外环境变化的影响。比如温度,包括测量过程中人体的体温以及环境温度,血压和环境湿度等参数的影响。同时近红外光谱也受整个心动周期血容量脉动的影响。而现有大多数研究关注的是近红外吸收与血糖浓度之间的关系,但没有考虑它们相对于时间的波动规律,以及环境因素和人体生理状态对人体血糖浓度的影响。A stable and reliable quantitative model is a key technology of near-infrared non-invasive blood glucose detection technology. Linear models such as Multiple Linear Regression (MLR), Principal Components Regression (PCR) and Partial Least Squares Regression (PLS) have been used in many studies. However, due to the complexity of blood components and the interaction between components, the linear method based on the Lambert-Beer law may not be able to fit the relationship between near-infrared absorbance and human blood glucose concentration well. On the other hand, the optical signal about blood glucose detected in vitro is very weak and is extremely susceptible to changes in human physiological parameters and in vitro environment. Such as temperature, including the body temperature of the human body during the measurement process and the influence of parameters such as ambient temperature, blood pressure, and ambient humidity. At the same time, near-infrared spectroscopy is also affected by blood volume pulsations throughout the cardiac cycle. However, most existing studies focus on the relationship between near-infrared absorption and blood glucose concentration, but do not consider their fluctuations with respect to time, as well as the influence of environmental factors and human physiological state on human blood glucose concentration.

发明内容Contents of the invention

有鉴于此,本发明的目的在于提供一种近红外光谱无创血糖检测网络模型训练方法。In view of this, the purpose of the present invention is to provide a near-infrared spectrum non-invasive blood glucose detection network model training method.

为达到上述目的,本发明提供如下技术方案:To achieve the above object, the present invention provides the following technical solutions:

近红外光谱无创血糖检测网络模型训练方法,该方法包括如下步骤:A near-infrared spectrum non-invasive blood glucose detection network model training method, the method includes the following steps:

1)针对指定的多个个体对象,在不同检测时段分别对各个个体对象进行人体血糖的近红外光吸光度、有创血糖浓度、收缩压、舒张压和脉率的检测,以及环境温度、环境湿度的采集;将每个个体对象每天检测得到的以上7个输入参数和有创血糖浓度值作为相应个体对象在当天的样本数据时间序列,从而得到多个个体对象的样本数据组;其中一部分个体对象的样本数据作为训练样本数据组,一部分个体对象的样本数据作为验证样本数据组,剩余个体对象的样本数据则作为测试样本数据组;1) For multiple designated individual subjects, the near-infrared absorbance of human blood glucose, invasive blood glucose concentration, systolic blood pressure, diastolic blood pressure and pulse rate are detected for each individual subject at different detection periods, as well as the ambient temperature and ambient humidity collection; the above 7 input parameters and invasive blood glucose concentration values detected by each individual subject every day are used as the sample data time series of the corresponding individual subject on the day, so as to obtain the sample data groups of multiple individual subjects; some of the individual subjects The sample data of the individual objects is used as the training sample data group, the sample data of a part of the individual objects is used as the verification sample data group, and the sample data of the remaining individual objects is used as the test sample data group;

2)将训练样本数据组中的7个输入参数和有创血糖浓度值分别作为输入变量和目标变量输入到BP人工神经网络,对人工神经网络进行训练,进而得到一个参数和结构确定的人工神经网络;2) Input the 7 input parameters and the invasive blood glucose concentration value in the training sample data group as input variables and target variables respectively into the BP artificial neural network, train the artificial neural network, and then obtain an artificial neural network with definite parameters and structure. network;

3)在训练好的BP网络的基础上进行敏感度分析;全部的样本用于敏感度分析,根据分析结果来排除不重要的变量,直到没有变量可以排除为止,保留下来的变量即为对血糖浓度影响明显的重要变量;3) Sensitivity analysis is performed on the basis of the trained BP network; all samples are used for sensitivity analysis, and unimportant variables are excluded according to the analysis results until no variables can be excluded, and the remaining variables are the blood glucose Important variables with significant concentration effects;

4)由筛选后的变量建立新的样本数据组,其中一部分个体对象的样本数据作为训练样本数据组,剩余个体对象的样本数据则作为测试样本数据组;筛选后的变量和有创血糖浓度值分别作为输入变量和目标变量输入到NARX网络,对网络进行训练,得到检测模型用于近红外无创血糖浓度检测。4) Create a new sample data set from the filtered variables, wherein the sample data of a part of the individual subjects is used as the training sample data set, and the sample data of the remaining individual subjects is used as the test sample data set; the filtered variables and invasive blood glucose concentration values The input variables and target variables are respectively input into the NARX network, and the network is trained to obtain a detection model for near-infrared non-invasive blood glucose concentration detection.

可选的,所述步骤2)具体为:Optionally, the step 2) is specifically:

21)确定网络结构共包含三层,输出层、输出层和一个隐含层;输入神经元个数为7,对应输出变量的个数,输出神经元个数为1,对应血糖浓度预测值;隐含层神经元个数根据Kolmogorov公式确定为15;21) Determine that the network structure includes three layers, an output layer, an output layer, and a hidden layer; the number of input neurons is 7, corresponding to the number of output variables, and the number of output neurons is 1, corresponding to the predicted value of blood sugar concentration; The number of neurons in the hidden layer is determined to be 15 according to the Kolmogorov formula;

22)采用Levenberg-Marquardt算法对网络进行训练;将全部的样本根据血糖浓度参考值随机选取出60%作为训练集,在训练过程中对网络进行训练;20%作为验证集,用来测量网络的泛化能力并终止网络训练过程;剩下的20%作为测试集对训练后的模型预测性能进行评价。22) Use the Levenberg-Marquardt algorithm to train the network; randomly select 60% of all samples according to the blood glucose concentration reference value as a training set, and train the network during the training process; 20% are used as a verification set to measure the network performance. Generalization ability and terminate the network training process; the remaining 20% is used as a test set to evaluate the prediction performance of the trained model.

可选的,所述步骤4)具体为:Optionally, the step 4) is specifically:

41)考虑到临床应用场景,对于每个用户,要保证较好的预测准确性的前提下尽可能的减少指尖采血的次数,故确定延迟阶数d=2;41) Considering the clinical application scenario, for each user, the number of fingertip blood collection should be reduced as much as possible under the premise of ensuring better prediction accuracy, so the delay order d=2 is determined;

42)同样根据Kolmogorov公式确定隐含层神经元个数;42) Also determine the number of neurons in the hidden layer according to the Kolmogorov formula;

43)采用Levenberg-Marquardt算法对网络进行训练;NARX网络训练过程中,网络采用开环模式,该模式在预测当前输出时提供的过去输出值为标准参考值,有利于提高模型的准确性;训练结束后,网络转换为闭环模式,用于实际问题中的预测。43) Use the Levenberg-Marquardt algorithm to train the network; during the NARX network training process, the network adopts an open-loop mode, which provides a standard reference value for the past output value when predicting the current output, which is conducive to improving the accuracy of the model; training After that, the network switches to closed-loop mode for prediction in real problems.

4、根据权利要求1所述的近红外光谱无创血糖检测网络模型训练方法,其特征在于,所述红外光谱为1550nm单波长的近红外光。4. The method for training a near-infrared spectrum non-invasive blood sugar detection network model according to claim 1, wherein the infrared spectrum is near-infrared light with a single wavelength of 1550nm.

基于所述训练方法的近红外光谱无创血糖检测方法,该方法包括如下步骤:Based on the near infrared spectrum non-invasive blood sugar detection method of described training method, this method comprises the following steps:

A)获取得到的NARX检测模型,用于近红外无创血糖检测;A) The obtained NARX detection model is used for near-infrared non-invasive blood glucose detection;

B)对待侧个体对象进行筛选后的输入参数的采集,得到该待测个体对象的输入样本数据;B) collecting the input parameters after screening the individual object to be tested, and obtaining the input sample data of the individual object to be tested;

C)将输入样本数据输入到上述方法得到的NARX检测模型,得到待测个体对象的血糖浓度预测值,作为该待测个体对象的近红外无创血糖检测结果。C) Input the input sample data into the NARX detection model obtained by the above method to obtain the predicted value of the blood glucose concentration of the individual subject to be tested as the near-infrared non-invasive blood glucose detection result of the individual subject to be tested.

本发明的有益效果在于:The beneficial effects of the present invention are:

1、实现少波长的近红外光谱的应用,有效提取血糖浓度的同时,避免了近红外光谱仪的使用。糖尿病患者或其家属在使用过程中不需要非常复杂的专业知识,即可对检测系统进行使用,有利于无创血糖检测仪的家用推广。1. Realize the application of near-infrared spectroscopy with few wavelengths, effectively extract blood sugar concentration, and avoid the use of near-infrared spectrometers. Diabetic patients or their family members do not need very complicated professional knowledge during use to use the detection system, which is conducive to the promotion of non-invasive blood glucose detectors at home.

2、初步引入了环境和受试者身体的生理参数,将这些因素对检测过程中近红外吸光度的影响考虑进来,有利于减小个体差异和环境因素对预测结果的影响,提高预测模型的精确度和鲁棒性。2. Preliminary introduction of the physiological parameters of the environment and the subject’s body, taking into account the influence of these factors on the near-infrared absorbance during the detection process, will help reduce the influence of individual differences and environmental factors on the prediction results, and improve the accuracy of the prediction model accuracy and robustness.

3、采用了SA分析方法进行初步引入的变量进行分析,筛选出对模型输出结果影响较大的几个关键变量,一方面有利于降低模型的复杂性,提高运算速度;另一方面排除掉冗余变量,能够有效防止过拟合,提高模型的预测精度和鲁棒性。3. The SA analysis method is used to analyze the initially introduced variables, and several key variables that have a greater impact on the model output results are screened out. On the one hand, it is beneficial to reduce the complexity of the model and improve the calculation speed; on the other hand, it eliminates redundant Residual variables can effectively prevent overfitting and improve the prediction accuracy and robustness of the model.

4、人体血糖浓度在一天内的波动具有一定的规律性。NARX模型不仅具备时间序列的模拟功能,还能够较好地刻画非线性关系,基于输入变量筛选的结果,建立NARX模型,能够有效地利用血糖浓度的时序波动规律,提高预测准确性。4. The fluctuation of human blood sugar concentration in a day has certain regularity. The NARX model not only has the simulation function of time series, but also can better describe the nonlinear relationship. Based on the results of input variable screening, the establishment of the NARX model can effectively use the time series fluctuation of blood glucose concentration and improve the prediction accuracy.

本发明的其他优点、目标和特征在某种程度上将在随后的说明书中进行阐述,并且在某种程度上,基于对下文的考察研究对本领域技术人员而言将是显而易见的,或者可以从本发明的实践中得到教导。本发明的目标和其他优点可以通过下面的说明书来实现和获得。Other advantages, objects and features of the present invention will be set forth in the following description to some extent, and to some extent, will be obvious to those skilled in the art based on the investigation and research below, or can be obtained from It is taught in the practice of the present invention. The objects and other advantages of the invention may be realized and attained by the following specification.

附图说明Description of drawings

为了使本发明的目的、技术方案和优点更加清楚,下面将结合附图对本发明作优选的详细描述,其中:In order to make the purpose of the present invention, technical solutions and advantages clearer, the present invention will be described in detail below in conjunction with the accompanying drawings, wherein:

图1为本发明的流程图;Fig. 1 is a flowchart of the present invention;

图2为典型的BP人工神经网络模型拓扑结构图;Fig. 2 is a typical BP artificial neural network model topological structure diagram;

图3为典型的NARX模型拓扑结构图;Figure 3 is a typical NARX model topology diagram;

图4为实施例中不同个体对象在不同天的NARX检测网络模型进行近红外光谱无创血糖检测结果以及偏差;Fig. 4 is the NARX detection network model of different individual objects in the embodiment on different days to carry out near-infrared spectrum non-invasive blood sugar detection results and deviation;

图5为本发明利用NARX检测网络模型进行近红外光谱无创血糖检测的克拉克误差网格图。Fig. 5 is a Clark error grid diagram of the present invention using the NARX detection network model for near-infrared spectrum non-invasive blood glucose detection.

具体实施方式Detailed ways

以下通过特定的具体实例说明本发明的实施方式,本领域技术人员可由本说明书所揭露的内容轻易地了解本发明的其他优点与功效。本发明还可以通过另外不同的具体实施方式加以实施或应用,本说明书中的各项细节也可以基于不同观点与应用,在没有背离本发明的精神下进行各种修饰或改变。需要说明的是,以下实施例中所提供的图示仅以示意方式说明本发明的基本构想,在不冲突的情况下,以下实施例及实施例中的特征可以相互组合。Embodiments of the present invention are described below through specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the content disclosed in this specification. The present invention can also be implemented or applied through other different specific implementation modes, and various modifications or changes can be made to the details in this specification based on different viewpoints and applications without departing from the spirit of the present invention. It should be noted that the diagrams provided in the following embodiments are only schematically illustrating the basic concept of the present invention, and the following embodiments and the features in the embodiments can be combined with each other in the case of no conflict.

其中,附图仅用于示例性说明,表示的仅是示意图,而非实物图,不能理解为对本发明的限制;为了更好地说明本发明的实施例,附图某些部件会有省略、放大或缩小,并不代表实际产品的尺寸;对本领域技术人员来说,附图中某些公知结构及其说明可能省略是可以理解的。Wherein, the accompanying drawings are for illustrative purposes only, and represent only schematic diagrams, rather than physical drawings, and should not be construed as limiting the present invention; in order to better illustrate the embodiments of the present invention, some parts of the accompanying drawings may be omitted, Enlargement or reduction does not represent the size of the actual product; for those skilled in the art, it is understandable that certain known structures and their descriptions in the drawings may be omitted.

本发明实施例的附图中相同或相似的标号对应相同或相似的部件;在本发明的描述中,需要理解的是,若有术语“上”、“下”、“左”、“右”、“前”、“后”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此附图中描述位置关系的用语仅用于示例性说明,不能理解为对本发明的限制,对于本领域的普通技术人员而言,可以根据具体情况理解上述术语的具体含义。In the drawings of the embodiments of the present invention, the same or similar symbols correspond to the same or similar components; , "front", "rear" and other indicated orientations or positional relationships are based on the orientations or positional relationships shown in the drawings, which are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the referred devices or elements must It has a specific orientation, is constructed and operated in a specific orientation, so the terms describing the positional relationship in the drawings are for illustrative purposes only, and should not be construed as limiting the present invention. For those of ordinary skill in the art, the understanding of the specific meaning of the above terms.

本实施例以多个志愿者作为训练检测网络模型的个体对象,本实施例以多个志愿者作为检测网络模型训练的个体对象,将人体手指的1550nm近红外光谱经过调理放大后,经数据采集卡传输至计算机中进行叠加平均滤波处理,得到1550nm单波长近红外光的近红外光谱。In this embodiment, a plurality of volunteers are used as individual objects for training the detection network model. In this embodiment, a plurality of volunteers are used as individual objects for the detection network model training. The card is transmitted to the computer for superposition and average filtering processing to obtain the near-infrared spectrum of 1550nm single-wavelength near-infrared light.

具体采集时,1550nm近红外光谱的采样频率为200Hz,连续采样20秒,将中间10秒的近红外光谱数据叠加求平均作为最后人体血糖检测的近红外光谱数据。During the specific collection, the sampling frequency of 1550nm near-infrared spectrum is 200Hz, continuous sampling is 20 seconds, and the near-infrared spectrum data in the middle 10 seconds are superimposed and averaged as the near-infrared spectrum data for the final human blood sugar detection.

数据采集前志愿者用20~30℃的水和肥皂洗手以保持双手清洁。然后用酒精擦拭测量部位并等待其干燥。为了避免手指结构差异的影响,将光谱检测部位固定为左手食指。要求每个志愿者舒适地坐在椅子上并将左手食指放入光学子系统的测试室。要求指尖稍微与准直器保持接触以避免变形。在采样过程中,测量位置和测量压力尽可能保持恒定。1550nm近红外光信号经过调理放大后,经数据采集卡传输至计算机中进行叠加平均滤波处理,得到1550nm单波长近红外光的近红外光谱。采样频率为200Hz,连续采样20秒,将中间10秒的近红外光谱数据叠加求平均得到1550nm近红外吸光度值。以上近红外光信号采集操作重复三次,并将平均值作为最终实验数据。然后通过One Touch Ultra Easy血糖仪测量相应的血糖浓度参考值。通过数字温度计和湿度计获得环境温度和湿度。用欧姆龙电子血压计测量志愿者的收缩压,舒张压和脉搏率。通过红外电子温度计测量志愿者的体温。上述环境和人体生理参数的测量重复三次,并记录平均值作为最终结果。Before data collection, volunteers washed their hands with water and soap at 20-30°C to keep their hands clean. Then wipe the measurement site with rubbing alcohol and wait for it to dry. In order to avoid the influence of finger structure differences, the spectral detection part is fixed as the left index finger. Each volunteer is asked to sit comfortably in a chair and place the left index finger into the test chamber of the optical subsystem. A fingertip is required to maintain slight contact with the collimator to avoid deformation. During the sampling process, the measuring position and the measuring pressure are kept as constant as possible. After the 1550nm near-infrared light signal is conditioned and amplified, it is transmitted to the computer through the data acquisition card for superposition and average filtering processing, and the near-infrared spectrum of the 1550nm single-wavelength near-infrared light is obtained. The sampling frequency is 200 Hz, the sampling is continuous for 20 seconds, and the near-infrared spectrum data in the middle 10 seconds are superimposed and averaged to obtain the near-infrared absorbance value at 1550 nm. The above near-infrared light signal acquisition operation was repeated three times, and the average value was used as the final experimental data. Then measure the corresponding blood glucose concentration reference value through the One Touch Ultra Easy blood glucose meter. Ambient temperature and humidity are obtained by digital thermometer and hygrometer. The systolic blood pressure, diastolic blood pressure and pulse rate of the volunteers were measured with an Omron electronic sphygmomanometer. The body temperature of the volunteers was measured by an infrared electronic thermometer. The measurement of the above environmental and human physiological parameters was repeated three times, and the average value was recorded as the final result.

本次实施例共招募了14名志愿者(9名女性和5名男性,年龄为22至25岁)。实验采集前告知了志愿者实验过程中所有可能存在的风险,并在征得志愿者同意后进行实验数据采集。实验于8:30开始,每个30分钟进行一次数据采集。每个志愿者的数据收集结束时间因个人情况而异。此外,一些志愿者参与了两天的数据采集,有些志愿者只参加了一天。表1显示了每位志愿者每天收集的实验数据(时间序列)的样本大小。例如,第一位志愿者在第一天共集了11个样本。最终本次实施例共采集到了205个样本数据。每个样本数据由环境温度(X1)、环境湿度(X2)、收缩压(X3)、舒张压(X4)、脉率(X5)、体温(X6)和1550nm近红外吸光度(X7)共7个输入变量以及有创血糖浓度参考值(Y)组成。测得的有创血糖浓度参考值范围为4.2~10mmol/L,标准偏差为1.35mmol/L。In this embodiment, a total of 14 volunteers (9 females and 5 males, aged 22 to 25 years old) were recruited. Before the experiment was collected, the volunteers were informed of all possible risks in the experiment process, and the experimental data were collected after obtaining the consent of the volunteers. The experiment started at 8:30 and data collection was performed every 30 minutes. The end time of data collection for each volunteer varied on an individual basis. In addition, some volunteers participated in two days of data collection, and some volunteers only participated in one day. Table 1 shows the sample size of the experimental data (time series) collected per day for each volunteer. For example, the first volunteer collected a total of 11 samples on the first day. Finally, a total of 205 sample data were collected in this embodiment. Each sample data consists of ambient temperature (X 1 ), ambient humidity (X 2 ), systolic blood pressure (X 3 ), diastolic blood pressure (X 4 ), pulse rate (X 5 ), body temperature (X 6 ) and 1550nm near-infrared absorbance (X 7 ) consisted of 7 input variables and the reference value of invasive blood glucose concentration (Y). The reference value range of the measured invasive blood glucose concentration was 4.2-10mmol/L, and the standard deviation was 1.35mmol/L.

表1实验数据信息Table 1 Experimental data information

然后,按照本发明的检测网络模型训练方法,来训练用于近红外光谱无创血糖检测的检测网络模型,训练流程如图1所示:Then, according to the detection network model training method of the present invention, the detection network model for near-infrared spectrum non-invasive blood sugar detection is trained, and the training process is as shown in Figure 1:

1)获得上述多个个体对象的血糖样本数据组。1) Obtain blood glucose sample data sets of the above-mentioned multiple individual subjects.

2)将训练样本数据组中的7个输入参数和有创血糖浓度值分别作为输入变量和目标变量输入到BP人工神经网络,对人工神经网络进行训练,进而得到一个参数和结构确定的人工神经网络;2) Input the 7 input parameters and the invasive blood glucose concentration value in the training sample data group as input variables and target variables respectively into the BP artificial neural network, train the artificial neural network, and then obtain an artificial neural network with definite parameters and structure. network;

21)BP神经网络典型的拓扑结构如图2所示。确定网络结构共包含三层,输出层、输出层和一个隐含层;输入神经元个数为7,对应输出变量的个数,输出神经元个数为1,对应血糖浓度预测值;隐含层神经元个数根据Kolmogorov公式确定为15。21) The typical topology of BP neural network is shown in Figure 2. Determine that the network structure consists of three layers, the output layer, the output layer and a hidden layer; the number of input neurons is 7, corresponding to the number of output variables, and the number of output neurons is 1, corresponding to the predicted value of blood sugar concentration; implicit The number of layer neurons is determined to be 15 according to the Kolmogorov formula.

22)采用Levenberg-Marquardt算法对网络进行训练。将全部的样本根据血糖浓度参考值随机选取出123个样本作为训练集对网络进行训练;41个样本作为验证集用于验证网络的泛化能力并及时终止训练过程;41个样本作为测试集用于评估训练后模型的性能。22) The network is trained using the Levenberg-Marquardt algorithm. 123 samples were randomly selected from all samples according to the blood glucose concentration reference value as the training set to train the network; 41 samples were used as the verification set to verify the generalization ability of the network and terminate the training process in time; 41 samples were used as the test set. to evaluate the performance of the trained model.

3)在训练好的BP网络的基础上进行敏感度分析。全部的样本用于敏感度分析,根据分析结果来排除不重要的变量,直到没有变量可以排除为止,保留下来的变量即为对血糖浓度影响明显的重要变量。3) Sensitivity analysis is performed on the basis of the trained BP network. All samples are used for sensitivity analysis, and unimportant variables are excluded according to the analysis results until no variables can be excluded, and the remaining variables are important variables that have a significant impact on blood glucose concentration.

31)首先进行第一轮筛选,在训练好的7变量BP网络的基础上对各变量进行敏感度分析,结果如表2中第一轮所示。根据Gap<0.5的判别标准,在当前的7变量BP网络中,输出对输入变量X1和X2的敏感度相对较低,将在后面的模型中被排除。31) Firstly, the first round of screening is carried out, and the sensitivity analysis of each variable is carried out on the basis of the trained 7-variable BP network. The results are shown in the first round in Table 2. According to the discriminant criterion of Gap<0.5, in the current 7-variable BP network, the sensitivity of the output to the input variables X1 and X2 is relatively low, which will be excluded in the later model.

32)然后进行第二轮筛选,由剩下的5个变量继续建立BP网络模型,再次进行敏感度分析,结果如表2中第二轮所示,同理排除变量X4。32) Then carry out the second round of screening, continue to build the BP network model from the remaining 5 variables, and conduct sensitivity analysis again. The results are shown in the second round in Table 2, and the variable X4 is excluded in the same way.

33)再进行第三轮筛选,由剩下的4个变量继续建立BP网络模型,进行敏感度分析,结果如表2中第三轮所示,当前由变量X3、X5、X6和X7组成的BP网络中,输出对于各输入变量的敏感度均相对较高,故变量筛选过程到此结束,可以认为该四个变量(收缩压、脉率、体温和1550nm吸光度)全部为血糖浓度预测模型的重要变量。33) Carry out the third round of screening, continue to build the BP network model from the remaining 4 variables, and conduct sensitivity analysis. The results are shown in the third round in Table 2. Currently, the variables X3, X5, X6 and X7 are composed of In the BP network, the sensitivity of the output to each input variable is relatively high, so the variable screening process ends here, and it can be considered that the four variables (systolic blood pressure, pulse rate, body temperature, and 1550nm absorbance) are all the parameters of the blood glucose concentration prediction model. important variable.

表2 敏感度分析结果Table 2 Sensitivity analysis results

4)由筛选后的四个变量(收缩压、脉率、体温和1550nm吸光度)以及有创血糖浓度参考值建立新的样本数据组,其中90%个体对象的样本数据作为训练样本数据组,剩余10%个体对象的样本数据则作为测试样本数据组。筛选后的变量和有创血糖浓度值分别作为输入变量和目标变量输入到NARX网络,对网络进行训练,得到检测模型用于近红外无创血糖浓度检测。4) Establish a new sample data set by the screened four variables (systolic blood pressure, pulse rate, body temperature, and 1550nm absorbance) and invasive blood glucose concentration reference values, wherein 90% of the sample data of individual subjects are used as training sample data sets, and the remaining The sample data of 10% of the individual subjects is used as the test sample data set. The filtered variables and invasive blood glucose concentration values were input into the NARX network as input variables and target variables, respectively, and the network was trained to obtain a detection model for near-infrared non-invasive blood glucose concentration detection.

41)图3为NARX网络的典型拓扑结构。考虑到临床应用场景,对于每个用户,要保证较好的预测准确性的前提下尽可能的减少指尖采血的次数,故确定延迟阶数d=2。41) Figure 3 is a typical topology of a NARX network. Considering the clinical application scenario, for each user, it is necessary to reduce the number of fingertip blood collection as much as possible under the premise of ensuring better prediction accuracy, so the delay order d=2 is determined.

42)同样根据Kolmogorov公式确定隐含层神经元个数为9。42) Also determine the number of neurons in the hidden layer to be 9 according to the Kolmogorov formula.

43)采用Levenberg-Marquardt算法对网络进行训练。NARX网络训练过程中,网络采用开环模式,该模式在预测当前输出时提供的过去输出值为标准参考值,有利于提高模型的准确性。训练结束后,网络转换为闭环模式,用于实际问题中的预测。43) The network is trained using the Levenberg-Marquardt algorithm. During the training process of the NARX network, the network adopts an open-loop mode, which provides a standard reference value for the past output value when predicting the current output, which is conducive to improving the accuracy of the model. After training, the network switches to closed-loop mode for prediction in practical problems.

44)由于NARX模型要求数据具有严格的时序性,故保留样本数据的原始顺序,将采集到的样本数据分为10组时间序列作为十折交叉验证数据集。图4为采用十折交叉验证方法,本次实施例中NARX的预测结果以及偏差。横标的标注形式为“Sa-b-c”,其中a表示检测的个体对象标记序号,b表示检测的天数标记(检测时段标记),c表示相应天数内(相应检测时段内)的血糖样本数据组个数标记;例如“S1-1-01”表示的是第1位个体对象在第1天内检测的第1个血糖样本数据组。由图3可以看到,大部分预测值比较接近实测参考值。44) Since the NARX model requires the data to have strict timing, the original order of the sample data is retained, and the collected sample data is divided into 10 groups of time series as a ten-fold cross-validation data set. Figure 4 shows the prediction results and deviations of NARX in this example using the ten-fold cross-validation method. The label format of the horizontal mark is "Sa-b-c", where a represents the serial number of the individual object to be tested, b represents the number of days of detection (mark of the detection period), and c represents the number of blood glucose sample data groups within the corresponding number of days (within the corresponding detection period). number mark; for example, "S1-1-01" indicates the first blood glucose sample data set detected by the first individual subject within the first day. It can be seen from Figure 3 that most of the predicted values are relatively close to the measured reference values.

图5为本发明NARX检测网络模型进行近红外光谱无创血糖检测的方法的克拉克误差网格分析图,预测结果均分布于区域A和B中,均满足临床要求。其中落于A区域的点所占比重为90.27%,落于B区域所占比重为9.73%。表明本发明基于NARX检测网络模型的近红外光谱无创血糖检测方法具有较高的检测精度。Fig. 5 is the Clark error grid analysis diagram of the NARX detection network model of the present invention for the method of non-invasive blood glucose detection by near-infrared spectroscopy. The prediction results are distributed in areas A and B, which meet the clinical requirements. Among them, the proportion of points falling in area A is 90.27%, and the proportion of points falling in area B is 9.73%. It shows that the non-invasive blood glucose detection method based on NARX detection network model of the present invention has high detection accuracy.

为了进一步说明本发明的NARX检测网络模型的性能,分别使用均方根误差(RMSE)、相关系数(CORR)和克拉克误差网格分析预测结果落入各区域的比例对其进行评估。各十折交叉验证集预测结果的各个参数如表3所示。最终总体交叉验证集预测结果均方根误差为0.72,相关系数为0.85。以上分析表明,本发明的NARX检测模型具有较高的检测精度和鲁棒性。In order to further illustrate the performance of the NARX detection network model of the present invention, the root mean square error (RMSE), the correlation coefficient (CORR) and the proportion of Clarke error grid analysis prediction results falling into each region are evaluated respectively. The parameters of the prediction results of each ten-fold cross-validation set are shown in Table 3. The root mean square error of the prediction results of the final overall cross-validation set is 0.72, and the correlation coefficient is 0.85. The above analysis shows that the NARX detection model of the present invention has high detection accuracy and robustness.

表3 NARX模型十折交叉验证集预测结果Table 3 Prediction results of NARX model ten-fold cross-validation set

综上所述,本发明用于近红外光谱无创血糖检测的网络模型训练方法。首先,根据人体血糖的近红外吸收特性,1550nm近红外对人体血糖的吸收最强,故确定1550nm近红外光谱为自变量,避免了近红外光谱仪的使用,使得设备更加便携,操作简便,价格低廉。人体组织结构复杂,近红外吸光度和血糖浓度并不严格符合朗伯比尔定律,其可能兼具线性和非线性关系,且人体血糖浓度日常波动具有一定的规律性,而NARX网络模型既能拟合线性和非线性关系,又具备时间序列的模拟功能。考虑到环境因素和人体生理参数对近红外吸光度的影响,增加引入环境温度、环境湿度、收缩压、舒张压、脉率和体温作为输入变量。为了克服自变量太多而导致信息冗余和模型的过拟合,采用了敏感度分析方法对初始引入的7个输入变量进行筛选,最终筛选出收缩压、脉率、体温和1550nm近红外吸光度四个输入变量作为NARX的输入变量,得到NARX模型。结果表明本文提出的NARX模型能够满足血糖无创检测的精度要求,一方面提升了血糖无创检测的精度,另一方面提升了模型的鲁棒性和泛化能力。To sum up, the present invention is a network model training method for near-infrared spectrum non-invasive blood glucose detection. First of all, according to the near-infrared absorption characteristics of human blood sugar, 1550nm near-infrared has the strongest absorption on human blood sugar, so the 1550nm near-infrared spectrum is determined as an independent variable, avoiding the use of near-infrared spectrometers, making the equipment more portable, easy to operate, and low in price . The structure of human tissue is complex, and the near-infrared absorbance and blood glucose concentration do not strictly conform to Lambert-Beer's law, which may have both linear and nonlinear relationships, and the daily fluctuation of human blood glucose concentration has certain regularity, and the NARX network model can both fit Linear and nonlinear relationships, but also has the simulation function of time series. Considering the influence of environmental factors and human physiological parameters on the near-infrared absorbance, ambient temperature, ambient humidity, systolic blood pressure, diastolic blood pressure, pulse rate and body temperature were added as input variables. In order to overcome information redundancy and model overfitting caused by too many independent variables, a sensitivity analysis method was used to screen the initially introduced seven input variables, and finally screened out systolic blood pressure, pulse rate, body temperature, and 1550nm near-infrared absorbance The four input variables are used as the input variables of NARX to obtain the NARX model. The results show that the NARX model proposed in this paper can meet the accuracy requirements of non-invasive blood glucose detection. On the one hand, it improves the accuracy of non-invasive blood glucose detection, and on the other hand, it improves the robustness and generalization ability of the model.

最后说明的是,以上实施例仅用以说明本发明的技术方案而非限制,尽管参照较佳实施例对本发明进行了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本技术方案的宗旨和范围,其均应涵盖在本发明的权利要求范围当中。Finally, it is noted that the above embodiments are only used to illustrate the technical solutions of the present invention without limitation. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that the technical solutions of the present invention can be carried out Modifications or equivalent replacements, without departing from the spirit and scope of the technical solution, should be included in the scope of the claims of the present invention.

Claims (5)

1. the near infrared spectrum noninvasive blood glucose detection network model training method is characterized by comprising the following steps:
1) Aiming at a plurality of specified individual subjects, respectively detecting the near infrared light absorbance, invasive blood glucose concentration, systolic pressure, diastolic pressure and pulse rate of human blood glucose of each individual subject at different detection time periods, and acquiring environmental temperature and environmental humidity; taking the 7 input parameters and the invasive blood glucose concentration value detected by each individual object every day as a sample data time sequence of the corresponding individual object on the same day, thereby obtaining a sample data group of a plurality of individual objects; the sample data of a part of individual objects is used as a training sample data set, the sample data of a part of individual objects is used as a verification sample data set, and the sample data of the rest individual objects is used as a test sample data set;
2) Inputting 7 input parameters and invasive blood sugar concentration values in a training sample data set into a BP artificial neural network as input variables and target variables respectively, training the artificial neural network, and further obtaining an artificial neural network with determined parameters and structure;
3) Carrying out sensitivity analysis on the basis of the trained BP network; all samples are used for sensitivity analysis, unimportant variables are excluded according to analysis results until no variable can be excluded, and the reserved variables are important variables which obviously influence the blood glucose concentration;
4) Establishing a new sample data set by the screened variables, wherein the sample data of a part of individual objects is used as a training sample data set, and the sample data of the rest individual objects is used as a test sample data set; and inputting the screened variable and the invasive blood glucose concentration value into an NARX network as an input variable and a target variable respectively, training the network, and obtaining a detection model for near-infrared noninvasive blood glucose concentration detection.
2. The near infrared spectrum noninvasive blood glucose detection network model training method of claim 1, wherein the step 2) is specifically:
21) Determining that the network structure comprises three layers, namely an output layer, an output layer and a hidden layer; the number of input neurons is 7, the number of output neurons corresponds to the number of output variables, the number of output neurons is 1, and the number corresponds to a blood glucose concentration predicted value; the number of the neurons in the hidden layer is determined to be 15 according to a Kolmogorov formula;
22) Training the network by adopting a Levenberg-Marquardt algorithm; randomly selecting 60% of all samples according to the blood glucose concentration reference value as a training set, and training the network in the training process; 20% is used as a verification set for measuring the generalization capability of the network and terminating the network training process; the remaining 20% was used as a test set to evaluate the prediction performance of the trained model.
3. The near infrared spectrum noninvasive blood glucose detection network model training method of claim 1, wherein the step 4) is specifically:
41) Considering a clinical application scene, for each user, on the premise of ensuring better prediction accuracy, the number of times of blood sampling of a fingertip is reduced as much as possible, so that the delay order d is determined to be 2;
42) determining the number of neurons in an implied layer according to a Kolmogorov formula;
43) Training the network by adopting a Levenberg-Marquardt algorithm; in the NARX network training process, the network adopts an open-loop mode, and the past output value provided by the mode when the current output is predicted is a standard reference value, so that the accuracy of the model is improved; after training is finished, the network is converted into a closed-loop mode for prediction in practical problems.
4. the near infrared spectroscopy noninvasive blood glucose detection network model training method of claim 1, wherein the infrared spectrum is 1550nm single wavelength near infrared light.
5. The near infrared spectrum noninvasive blood glucose detection method based on the training method of any one of claims 1 to 4 is characterized by comprising the following steps:
A) The obtained NARX detection model is used for near-infrared noninvasive blood glucose detection;
B) acquiring input parameters after screening individual objects to be tested to obtain input sample data of the individual objects to be tested;
C) Inputting the input sample data into the NARX detection model obtained by the method to obtain the blood glucose concentration predicted value of the individual object to be detected, and taking the predicted value as the near-infrared noninvasive blood glucose detection result of the individual object to be detected.
CN201910853592.4A 2019-09-10 2019-09-10 Near-infrared spectroscopy non-invasive blood glucose detection network model training method Pending CN110575181A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910853592.4A CN110575181A (en) 2019-09-10 2019-09-10 Near-infrared spectroscopy non-invasive blood glucose detection network model training method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910853592.4A CN110575181A (en) 2019-09-10 2019-09-10 Near-infrared spectroscopy non-invasive blood glucose detection network model training method

Publications (1)

Publication Number Publication Date
CN110575181A true CN110575181A (en) 2019-12-17

Family

ID=68812859

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910853592.4A Pending CN110575181A (en) 2019-09-10 2019-09-10 Near-infrared spectroscopy non-invasive blood glucose detection network model training method

Country Status (1)

Country Link
CN (1) CN110575181A (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111588384A (en) * 2020-05-27 2020-08-28 京东方科技集团股份有限公司 Method, device and equipment for obtaining blood sugar detection result
CN112043287A (en) * 2020-09-30 2020-12-08 重庆大学 Cerebral blood oxygen non-invasive monitoring method and monitoring device
CN113133762A (en) * 2021-03-03 2021-07-20 刘欣刚 Noninvasive blood glucose prediction method and device
EP3858238A1 (en) 2020-01-31 2021-08-04 trinamiX GmbH Portable device and method for providing treatment data to a user
WO2021178772A1 (en) * 2020-03-06 2021-09-10 Verily Life Sciences Llc Core temperature estimation from skin and ambient temperature sensors using a dynamic model
CN114403866A (en) * 2022-01-28 2022-04-29 广东工业大学 Noninvasive blood glucose prediction device based on near-infrared light wavelength conversion
US11357426B2 (en) * 2020-01-15 2022-06-14 Bao Tran Glucose management
CN114668393A (en) * 2021-08-19 2022-06-28 北京福乐云数据科技有限公司 Arm-wearing artificial intelligence blood glucose meter
CN115299938A (en) * 2022-07-18 2022-11-08 长春理工大学 Noninvasive blood glucose detection method capable of improving detection precision and robustness universality
WO2022261917A1 (en) * 2021-06-17 2022-12-22 广州视源电子科技股份有限公司 Apparatus that can implement non-invasive blood glucose testing, and device
CN115736907A (en) * 2021-09-04 2023-03-07 天津大学 Wearable microwave nondestructive testing human blood sugar based on cascade convolution neural network
CN115736910A (en) * 2022-10-31 2023-03-07 安徽奇智科技有限公司 Method for shortening heat exchange time between noninvasive blood glucose sensing probe and skin
CN116559143A (en) * 2023-05-15 2023-08-08 西北大学 Method and system for analyzing composite Raman spectrum data of glucose component in blood
CN116602668A (en) * 2023-07-06 2023-08-18 深圳大学 A fully automatic intelligent blood glucose detection system
CN117084677A (en) * 2023-10-17 2023-11-21 广东百年医疗健康科技发展有限公司 Multidimensional PPG blood glucose value estimation method
PL443399A1 (en) * 2023-01-02 2023-12-18 Advanced Diagnostic Equipment Spółka Z Ograniczoną Odpowiedzialnością Method for processing breath biomarker data, portable device for analyzing the analyte content and biomarker concentration, and computer program product
CN117770806A (en) * 2023-12-13 2024-03-29 苏州泽声微电子有限公司 Blood glucose monitoring method
CN119949821A (en) * 2025-04-11 2025-05-09 中国科学院西安光学精密机械研究所 A high-precision miniature infrared multi-spectral blood sugar measuring device and its measuring method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103198211A (en) * 2013-03-08 2013-07-10 北京理工大学 Quantitative analysis method for influences of attack risk factors of type 2 diabetes on blood sugar
CN107192690A (en) * 2017-05-19 2017-09-22 重庆大学 Near infrared spectrum Noninvasive Blood Glucose Detection Methods and its detection network model training method
CN108324286A (en) * 2018-01-26 2018-07-27 重庆大学 A kind of infrared light noninvasive dynamics monitoring device based on PCA-NARX correcting algorithms
CN108937955A (en) * 2017-05-23 2018-12-07 广州贝塔铁克医疗生物科技有限公司 The adaptive wearable blood glucose bearing calibration of personalization and its means for correcting based on artificial intelligence

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103198211A (en) * 2013-03-08 2013-07-10 北京理工大学 Quantitative analysis method for influences of attack risk factors of type 2 diabetes on blood sugar
CN107192690A (en) * 2017-05-19 2017-09-22 重庆大学 Near infrared spectrum Noninvasive Blood Glucose Detection Methods and its detection network model training method
CN108937955A (en) * 2017-05-23 2018-12-07 广州贝塔铁克医疗生物科技有限公司 The adaptive wearable blood glucose bearing calibration of personalization and its means for correcting based on artificial intelligence
CN108324286A (en) * 2018-01-26 2018-07-27 重庆大学 A kind of infrared light noninvasive dynamics monitoring device based on PCA-NARX correcting algorithms

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11357426B2 (en) * 2020-01-15 2022-06-14 Bao Tran Glucose management
US12076136B2 (en) * 2020-01-15 2024-09-03 Bao Tran Smart watch
US20220265178A1 (en) * 2020-01-15 2022-08-25 Bao Tran Smart watch
EP3858238A1 (en) 2020-01-31 2021-08-04 trinamiX GmbH Portable device and method for providing treatment data to a user
WO2021178772A1 (en) * 2020-03-06 2021-09-10 Verily Life Sciences Llc Core temperature estimation from skin and ambient temperature sensors using a dynamic model
US12082911B2 (en) 2020-03-06 2024-09-10 Verily Life Sciences Llc Core temperature estimation from skin and ambient temperature sensors using a dynamic model
CN111588384A (en) * 2020-05-27 2020-08-28 京东方科技集团股份有限公司 Method, device and equipment for obtaining blood sugar detection result
CN111588384B (en) * 2020-05-27 2023-08-22 京东方科技集团股份有限公司 Method, device and equipment for obtaining blood glucose detection result
CN112043287A (en) * 2020-09-30 2020-12-08 重庆大学 Cerebral blood oxygen non-invasive monitoring method and monitoring device
CN113133762A (en) * 2021-03-03 2021-07-20 刘欣刚 Noninvasive blood glucose prediction method and device
WO2022261917A1 (en) * 2021-06-17 2022-12-22 广州视源电子科技股份有限公司 Apparatus that can implement non-invasive blood glucose testing, and device
CN114668393A (en) * 2021-08-19 2022-06-28 北京福乐云数据科技有限公司 Arm-wearing artificial intelligence blood glucose meter
CN115736907A (en) * 2021-09-04 2023-03-07 天津大学 Wearable microwave nondestructive testing human blood sugar based on cascade convolution neural network
CN114403866B (en) * 2022-01-28 2022-08-19 广东工业大学 Noninvasive blood sugar prediction device based on near-infrared light wavelength conversion
CN114403866A (en) * 2022-01-28 2022-04-29 广东工业大学 Noninvasive blood glucose prediction device based on near-infrared light wavelength conversion
CN115299938A (en) * 2022-07-18 2022-11-08 长春理工大学 Noninvasive blood glucose detection method capable of improving detection precision and robustness universality
CN115736910A (en) * 2022-10-31 2023-03-07 安徽奇智科技有限公司 Method for shortening heat exchange time between noninvasive blood glucose sensing probe and skin
PL443399A1 (en) * 2023-01-02 2023-12-18 Advanced Diagnostic Equipment Spółka Z Ograniczoną Odpowiedzialnością Method for processing breath biomarker data, portable device for analyzing the analyte content and biomarker concentration, and computer program product
CN116559143A (en) * 2023-05-15 2023-08-08 西北大学 Method and system for analyzing composite Raman spectrum data of glucose component in blood
CN116602668B (en) * 2023-07-06 2023-10-31 深圳大学 A fully automatic intelligent blood glucose detection system
CN116602668A (en) * 2023-07-06 2023-08-18 深圳大学 A fully automatic intelligent blood glucose detection system
CN117084677A (en) * 2023-10-17 2023-11-21 广东百年医疗健康科技发展有限公司 Multidimensional PPG blood glucose value estimation method
CN117084677B (en) * 2023-10-17 2023-12-19 广东百年医疗健康科技发展有限公司 Multidimensional PPG blood glucose value estimation method
CN117770806A (en) * 2023-12-13 2024-03-29 苏州泽声微电子有限公司 Blood glucose monitoring method
CN119949821A (en) * 2025-04-11 2025-05-09 中国科学院西安光学精密机械研究所 A high-precision miniature infrared multi-spectral blood sugar measuring device and its measuring method
CN119949821B (en) * 2025-04-11 2025-07-11 中国科学院西安光学精密机械研究所 A high-precision miniature infrared multi-spectral blood sugar measuring device and its measuring method

Similar Documents

Publication Publication Date Title
CN110575181A (en) Near-infrared spectroscopy non-invasive blood glucose detection network model training method
Joshi et al. iGLU 2.0: A new wearable for accurate non-invasive continuous serum glucose measurement in IoMT framework
Zhang et al. A noninvasive blood glucose monitoring system based on smartphone PPG signal processing and machine learning
Habbu et al. Estimation of blood glucose by non-invasive method using photoplethysmography
Yu et al. An accurate noninvasive blood glucose measurement system using portable near-infrared spectrometer and transfer learning framework
Gabriely et al. Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia.
Pai et al. Cloud computing-based non-invasive glucose monitoring for diabetic care
CN108324286B (en) Infrared noninvasive blood glucose detection device based on PCA-NARX correction algorithm
CN106901705A (en) A kind of unaware human Body Physiology Multi-parameter harvester and acquisition method and application
Tronstad et al. Non-invasive prediction of blood glucose trends during hypoglycemia
CN104224196A (en) Noninvasive blood component concentration measuring method
Feng et al. Noninvasive blood glucose monitor via multi-sensor fusion and its clinical evaluation
Nie et al. Blood glucose prediction based on imagingphotoplethysmography in combination with Machine learning
Gupta et al. In-vivo estimation of glucose level using PPG signal
JP4928849B2 (en) Non-invasive measuring device
CN114886421B (en) Near infrared-based high-precision noninvasive blood glucose concentration detection system and method
CN112836647B (en) A non-invasive triglyceride estimation system based on PPG signal
Li et al. A dynamic spectrum optimized single-trail extraction method for noninvasive analysis of human blood components
Fu et al. Fingertip capillary dynamic near infrared spectrum (DNIRS) measurement combined with multivariate linear modification algorithm for noninvasive blood glucose monitoring
CN118173264A (en) Noninvasive blood glucose concentration prediction method
Devakumar et al. Review on non invasive glucose and cholesterol measurement system
Apar et al. Development of Portable Device for Measurement of Blood Glucose, Temperature and Pulse-Oximeter using Arduino
Udara et al. DiabiTech-non-invasive blood glucose monitoring system
Xiao et al. Evaluation of dynamic spectrum extraction method based on salami slicing method
Preejith et al. High altitude study on finger reflectance SpO 2

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20191217